Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1 for 1₹2.7 LAccepted-AOC 7 1 27 AMEERPET HYDERABAD TELANGANA INDIA 500016 | HYDERABAD | HYDERABAD | TELANGANA | 500016 | ₹2.7 L | L1 for 1 | Accepted-AOC Being L1 for 1 drugs |
| 2 | L1 for 1₹3.9 LAccepted-AOC | ₹3.9 L | L1 for 1 | Accepted-AOC Being L1 for 1 drugs |
| 3 | L1 for 4₹6.7 LAccepted-AOC | ₹6.7 L | L1 for 4 | Accepted-AOC Being L1 for 4 drugs |
| 4 | L1 for 1₹10 LAccepted-AOC | ₹10 L | L1 for 1 | Accepted-AOC Being L1 for 1 drugs |
| 5 | L1 for 1₹13.2 LAccepted-AOC | ₹13.2 L | L1 for 1 | Accepted-AOC Being L1 for 1 drugs |
| Sl No | Description | Qty | Unit | Roche Products India Pvt Ltd L19 | THERDOSE PHARMA PVT LTD L15 | Intas Pharmaceuticals Ltd. L34 | Dr.Reddys LAboratories Limited L22 | MSD Pharmaceuticals Private Limited L10 | Reliance Life Sciences Private Limited L30 | Johnson and Johnson Private Limited L12 | AstraZeneca Pharma India Limited L5 | Fresenius Kabi Oncology Limited L27 | NEON LABORATORIES LIMITED L24 | Novartis Health Care Private Limited L7 | Eli Lilly And Company India Pvt Ltd L3 | Khandelwal Laboratories Pvt. Ltd. L21 | Hetero Healthcare limited L29 | Cipla Ltd L9 | Merck Specialities Pvt Ltd L13 | GLS PHARMA LTD. L26 | Samarth Life Sciences Pvt. Ltd. L25 | MSN Laboratories Private Limited L18 | Beta Drugs Limited L32 | Getwell Pharma India Private Limited L14 | Shilpa Medicare Limited L6 | Biocon Biologics Limited L1 | M/s Adley Formulation Private Limited L16 | United Biotech (P) Ltd L23 | Pfizer Products India Pvt. Ltd. L4 | NATCO PHARMA LIMITED L28 | BHARAT SERUMS AND VACCINES LIMITED L8 | EMCURE PHARMACEUTICALS LIMITED L2 | BRUCK PHARMA PVT LTD L20 | Bristol-Myers Squibb India Private Limited L11 | Medicamen Biotech Limited L17 | Zydus Lifesciences Limited L31 | BDR Pharmaceuticals International Pvt. Ltd. L33 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | ABIRATERONE TAB IP, 250 mg | 1 | 1 no | - | - | - | - | - | - | - | - | - | - | - | - | - | 20.49 ₹1,37,70,000 Lowest | - | - | - | 25.2 ₹1,69,32,000 | 35 ₹2,35,20,000 | 22.38 ₹1,50,42,000 | - | - | - | - | - | - | - | - | - | 27 ₹1,81,44,000 | - | 24.3 ₹1,63,32,000 | - | 22.5 ₹1,51,20,000 |
| 2.00 | ACTINOMYCIN D INJ, 0.5mg/3ml | 1 | Vial | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 3.00 | AMIFOSTINE FOR INJ USP, 500mg | 1 | Vial | - | 1,440 ₹2,58,048 Lowest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 4.00 | ANASTRAZOLE TAB IP, 1mg | 1 | 1 No | - | - | - | - | - | - | - | - | - | 3.65 ₹1,67,690 | - | - | - | 1.17 ₹53,710 Lowest | - | - | - | 1.8 ₹82,820 | - | - | - | - | - | - | - | - | 7.2 ₹3,30,460 | - | - | - | - | - | 1.4 ₹64,370 | - |
| 5.00 | ARSENIC TRIOXIDE INJ, 10 mg | 1 | Vial | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 112 ₹2,50,880 Lowest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 6.00 | AXITINIB TAB, 5 mg | 1 | 1 No | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 78 ₹1,31,040 | - | - | - | - | - | 2,042.86 ₹34,32,000 | - | - | - | - | - | 44.1 ₹74,085 Lowest | - | 144 ₹2,41,920 |
| 7.00 | AZACITIDINE INJ, 100 mg | 1 | Vial | - | 550 ₹92,40,000 | 635 ₹1,06,68,000 | 548 ₹92,06,400 | - | 660 ₹1,10,88,000 | - | - | - | - | - | - | - | - | - | - | - | - | 550 ₹92,40,000 | 538 ₹90,38,400 Lowest | 666 ₹1,11,88,800 | 574 ₹96,43,200 | - | - | - | - | - | - | - | - | - | - | - | - |
| 8.00 | AZACITIDINE TAB, 300 mg | 1 | 1 No | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 385 ₹86,24,000 | - | - | - | - | - | - | - | - | - | - | - | - | - | 321.43 ₹72,00,000 Lowest |
| 9.00 | BENDAMUSTINE INJ IP, 100mg | 1 | Vial | - | 550 ₹7,39,200 | - | - | - | - | - | - | 1,520 ₹20,42,880 | - | - | - | - | - | - | - | 565 ₹7,59,360 | - | - | 648 ₹8,70,912 | 548 ₹7,36,512 | - | - | - | - | - | 540 ₹7,25,760 Lowest | - | - | - | - | - | - | 702 ₹9,43,488 |
| 10.00 | BEVACIZUMAB INJ., 100mg | 1 | Vial | - | - | 1,368 ₹1,43,64,000 | 1,339 ₹1,40,59,500 | - | 1,395 ₹1,46,47,500 | - | - | - | - | - | - | - | 1,302 ₹1,36,71,000 Lowest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1,895 ₹1,98,97,500 | - |
Tender Value
Refer Docs
EMD Value
₹1 L
Closing Date
23 May 2025, 5:00 pmClosed
DIRECTOR
Regional Cancer Centre, Medical College PO, Thiruvananthapuram, Kerala, PIN-695011
Supply 187 Anti Cancer (Generic / Innovator on demand) Drugs on rate contract basis to Regional Cancer Centre,Thiruvananthapuram
2025_RCC_763290_1
03/RCC/2025-26/E9274/P2
Open Tender
Medicines
Supply
30 days
Regional Cancer Centre
Please refer Tender documents.
14 documents required · 14 mandatory
₹25,000
₹1 L
31 Jul 2026
5 May 2025
26 May 2025
5 May 2025
23 May 2025
6 May 2025
5 May 2025 - 23 May 2025
stage.html
html • 0.19 MB
tech_bid_open.pdf
tech_eval.pdf
fin_bid_open.pdf
boq_comp_chart.xlsx
xlsx
fin_eval.pdf
aoc.pdf
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .